D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
By M. Sasako, T. Sano, Seiichiro Yamamoto, Y. Kurokawa, A. Nashimoto, A. Kurita, M. Hiratsuka, T. Tsujinaka, T. Kinoshitá, K. Arai and 2 more. New England Journal of Medicine, 2008
870 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/15a085b759157fc664d103ceeda2acf16a7587bc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
In Surgery
Citations in the corpus
- Japanese gastric cancer treatment guidelines 2014 (ver. 4) (2016, methodology): “Systemic para-aortic lymph node dissection (PAND) had been attempted in Japan as clinical studies until its survival benefit was denied in a randomized trial in which only patients without lymphadenopathy in the para-aortic region were eligible [5].”
- Japanese gastric cancer treatment guidelines 2010 (ver. 3) (2011, background): “Its role has been discussed as follows: – The benefit of prophylactic para-aortic lymphadenectomy was denied by the Japanese randomized controlled trial (RCT) JCOG 9501 [5].”